Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Anti-Oxidant Activity of Novel 5-Substituted Arylidene-3-Substituted- Benzyl-Thiazolidine-2, 4-Diones


Affiliations
1 Faculty of Pharmacy, Babu Banarasi Das National Institute of Technology and Management, Lucknow 227105 (UP), India
     

   Subscribe/Renew Journal


A series of 5-substituted-arylidene-3-substituted-benzyl-thiazolidine-2, 4-dione derivatives were synthesized from thaizolidinedione and substituted benzyl chloride followed by the addition of substituted aromatic aldehydes. All the compounds 1(a)-1(e) and 2(a)-2(c) were screened for their in vitro antioxidant activity using DPPH method. The anisaldehyde based thiazolidinedione compounds 1(a) and 2(a) displayed good activity comparable to those of standard.


Keywords

Thiazolidine-2, 4-Dione, Heterocyclic Compounds, Antioxidant Activity.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 192

PDF Views: 1




  • Anti-Oxidant Activity of Novel 5-Substituted Arylidene-3-Substituted- Benzyl-Thiazolidine-2, 4-Diones

Abstract Views: 192  |  PDF Views: 1

Authors

Sachin Malik
Faculty of Pharmacy, Babu Banarasi Das National Institute of Technology and Management, Lucknow 227105 (UP), India
Ashish Choudhary
Faculty of Pharmacy, Babu Banarasi Das National Institute of Technology and Management, Lucknow 227105 (UP), India

Abstract


A series of 5-substituted-arylidene-3-substituted-benzyl-thiazolidine-2, 4-dione derivatives were synthesized from thaizolidinedione and substituted benzyl chloride followed by the addition of substituted aromatic aldehydes. All the compounds 1(a)-1(e) and 2(a)-2(c) were screened for their in vitro antioxidant activity using DPPH method. The anisaldehyde based thiazolidinedione compounds 1(a) and 2(a) displayed good activity comparable to those of standard.


Keywords


Thiazolidine-2, 4-Dione, Heterocyclic Compounds, Antioxidant Activity.